EUVIMEDEUVIMED entdecken
Crossref

Investigation of MHR-nephropathy relationship and the effect of SGLT2is on MHR in patients with type 2 diabetes

Bedriye Gizem Tekin, Erengül Pektaş

Irish Journal of Medical Science (1971 -) · 2024

DOI: 10.1007/s11845-024-03638-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Irish Journal of Medical Science (1971 -), 2024. Verfasst von Bedriye Gizem Tekin und 1 weiteren Autor:innen. Beteiligte Einrichtung: 25-Aralık State Hospital, Gaziantep, Turkey. gizemhacimustafaoglu@gmail.com. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Diabetic Nephropathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The aim of this study was to evaluate the relationship between monocyte/high-density lipoprotein (HDL) ratio (MHR), an inflammatory marker, and diabetic nephropathy (DN), a microvascular complication of diabetes in diabetic patients and to investigate the effect of sodium-glucose co-transporter 2 inhibitors (SGLT2i) on MHR. MATERIAL AND METHODS: The study included 119 diabetic patients. Hemogram, glucose, HbA1c, urea, creatinine, albumin, HDL cholesterol, LDL cholesterol, triglycerides, total cholesterol, MHR, NLR (neutrophil-lymphocyte ratio), and CRP parameters were evaluated in blood parameters taken after 8-10 h of fasting before and 6 months after SGLT2 inhibitor use, and albumin, creatinine, and albumin/creatinine parameters were evaluated in urine samples. Parameters were compared according to nephropathy status and SGLT2i type used. RESULTS: The MHR in diabetic nephropathy (DN (+)) patients was significantly higher than in DN (-) patients (p = 0.005). There was no significant difference in NLR value in both groups. The MHR value decreased significantly after the use of SGLT2i in all patients participating in the study (p = 0.01). NLR value decreased in DN (-) patients after SGLT2i use. No difference was observed in DN (+) patients. CONCLUSION: In this study, results supporting the relationship between DN and MHR and the effect of SGLT2i drugs on MHR were found. The use of MHR value as a marker in clinical course monitoring and shaping the treatment according to these markers may be useful in terms of prediction and treatment of complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsDiabetic NephropathiesHumansFemaleMaleMiddle AgedAgedMonocytesLipoproteins, HDLBiomarkers

Stichwörter der Autor:innen

Diabetes mellitusMHRNLRNephropathySGLT2

Substanzen

Sodium-Glucose Transporter 2 InhibitorsLipoproteins, HDLBiomarkers

Autor:innen und Institutionen

  • 25-Aralık State Hospital, Gaziantep, Turkey. gizemhacimustafaoglu@gmail.com.
  • 25-Aralık State Hospital, Gaziantep, Turkey.

Zitieren

APA

Tekin, B. G., & Pektaş, E. (2024). Investigation of MHR-nephropathy relationship and the effect of SGLT2is on MHR in patients with type 2 diabetes. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-024-03638-0

Vancouver

Tekin BG, Pektaş E. Investigation of MHR-nephropathy relationship and the effect of SGLT2is on MHR in patients with type 2 diabetes. Irish Journal of Medical Science (1971 -). 2024. doi:10.1007/s11845-024-03638-0

BibTeX
@article{Tekin2024,
  author = {Tekin, Bedriye Gizem and Pektaş, Erengül},
  title = {Investigation of MHR-nephropathy relationship and the effect of SGLT2is on MHR in patients with type 2 diabetes},
  journal = {Irish Journal of Medical Science (1971 -)},
  year = {2024},
  doi = {10.1007/s11845-024-03638-0}
}
Kostenlos starten →